A Single Center Single Dose Open-label Randomized Two Period Crossover Study to Determine the Bioavailability of Two Formulations of Methotrexate 25 mg Administered by Needle Injection and a Pre-filled Needle-free Device in at Least 48 Healthy Volunteers
Latest Information Update: 13 Nov 2025
At a glance
- Drugs Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Crossject
Most Recent Events
- 13 Nov 2025 New trial record